Sage Mountain Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Sell |
4,122
-356
| -8% | -$24.9K | 0.02% | 336 |
|
|
2025
Q1 | $329K | Buy |
4,478
+147
| +3% | +$10.8K | 0.02% | 282 |
|
|
2024
Q4 | $284K | Sell |
4,331
-2,570
| -37% | -$168K | 0.02% | 303 |
|
|
2024
Q3 | $538K | Buy |
6,901
+411
| +6% | +$32K | 0.05% | 190 |
|
|
2024
Q2 | $506K | Buy |
6,490
+473
| +8% | +$36.9K | 0.05% | 171 |
|
|
2024
Q1 | $408K | Buy |
6,017
+158
| +3% | +$10.7K | 0.04% | 191 |
|
|
2023
Q4 | $395K | Sell |
5,859
-320
| -5% | -$21.6K | 0.05% | 160 |
|
|
2023
Q3 | $418K | Buy |
6,179
+2,867
| +87% | +$194K | 0.06% | 137 |
|
|
2023
Q2 | $237K | Sell |
3,312
-31
| -0.9% | -$2.22K | 0.03% | 217 |
|
|
2023
Q1 | $232K | Buy |
+3,343
| New | +$232K | 0.04% | 205 |
|